Dallas-based BioLum Sciences was founded by three former Southern Methodist University students, Miguel Quimbar, Edward Allegra, Jack Reynolds [Photo courtesy of TriTex]
Dallas-based BioLum Sciences has received another round of funding from Intelis Capital, which invests in early stage ventures.
The startup co-founded by Southern Methodist University graduates is working on a non-invasive device for asthma management. The device measures airway inflammation though a breath scan and will correspond with an app so patients and doctors can keep track of an individual’s health, according to the BioLum website.
The amount of this latest funding round was not disclosed, according to D CEO Healthcare’s Olivia Nguyen, BioLum did say the investment would be used for product development, commercialization, and the clinical trials it expects to begin next year.
“We have one ultimate goal for the rest of the year: to have a commercially viable device ready for clinical trials by 2018,” BioLum CEO and Co-founder Edward Allegra said in a statement to D CEO Healthcare.
Watch next:
Click the image to watch a video on BioLum published in November 2016 on YouTube.
Dallas Innovates, every day
View previous emails.
R E A D N E X T
-
Five local winners received up to $200,000 in funding to activate their solutions throughout North Texas.
-
Two nonprofits will each receive $250,000 in grant funding. The Capital One grants are part of a $3.5 million commitment to 12 nonprofit organizations.
-
To prevent suicides, hunger, and learning issues, Rhithm's emojified bio-social assessments app lets kids say how they feel.
-
Women entrepreneurs in North Texas and across the U.S. have long faced challenges in finding funding for their businesses. Now Bank of America is stepping in to help "bridge the capital gap" with its new Access to Capital platform. The online resource educates women entrepreneurs on ways they can fund their businesses, and covers more than 350 sources of capital.
-
The noninvasive technology—developed in collaboration with Austin-based Shani Biotechnologies—may enable real-time monitoring of vital blood parameters like hemoglobin, without taking blood samples or using expensive equipment. It could be especially useful for monitoring people of color, helping to close racial disparities in health care diagnostics.